July 6, 2020
The Globe and Mail | Top Canadian Biotech Investor on the Firms Most Likely to Turn COVID-19 Drug Trials into Treatments and When a Vaccine May Arrive
Our CEO, Brian Bloom, was featured in The Globe and Mail. He shares his thoughts with Tim Shufelt and describes the current biotech landscape, with a special focus on Canadian companies that are contributing to COVID-19 pandemic research and drug development.
Read the original article here.
